|
TOR1AIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.000400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.048620E-01 |
| Normal-vs-Stage2 |
1.525230E-01 |
| Normal-vs-Stage3 |
1.828970E-04 |
| Normal-vs-Stage4 |
1.79279999734661E-08 |
| Stage1-vs-Stage2 |
6.226400E-01 |
| Stage1-vs-Stage3 |
6.699600E-03 |
| Stage1-vs-Stage4 |
1.52498000000056E-05 |
| Stage2-vs-Stage3 |
1.763760E-01 |
| Stage2-vs-Stage4 |
4.596800E-03 |
| Stage3-vs-Stage4 |
8.266200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.186900E-04 |
| Normal-vs-AfricanAmerican |
5.432700E-04 |
| Normal-vs-Asian |
1.469820E-01 |
| Caucasian-vs-AfricanAmerican |
1.312960E-01 |
| Caucasian-vs-Asian |
8.714800E-01 |
| AfricanAmerican-vs-Asian |
6.518000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.988000E-04 |
| Normal-vs-Female |
7.179100E-03 |
| Male-vs-Female |
5.500000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.299660E-02 |
| Normal-vs-Age(41-60Yrs) |
6.544900E-03 |
| Normal-vs-Age(61-80Yrs) |
7.032300E-04 |
| Normal-vs-Age(81-100Yrs) |
7.876300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.689400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.008000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.415800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.005000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.309800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.364400E-02 |
| Normal-vs-Grade 2 |
1.669640E-01 |
| Normal-vs-Grade 3 |
9.60960000000455E-05 |
| Normal-vs-Grade 4 |
1.1964995660918E-10 |
| Grade 1-vs-Grade 2 |
7.649600E-02 |
| Grade 1-vs-Grade 3 |
3.656900E-03 |
| Grade 1-vs-Grade 4 |
2.93439999998757E-06 |
| Grade 2-vs-Grade 3 |
6.578300E-03 |
| Grade 2-vs-Grade 4 |
5.90669999578353E-08 |
| Grade 3-vs-Grade 4 |
2.971800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.220800E-01 |
| Normal-vs-ccB subtype |
3.98120000000279E-05 |
| ccA subtype-vs-ccB subtype |
4.85569999986168E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.296800E-03 |
| Normal-vs-N1 |
3.650800E-01 |
| N0-vs-N1 |
8.781800E-01 |
|
|
